- Dana-Farber President and CEO Dr. Edward J. Benz, Jr., discussed the ongoing war on cancer and where the promising research is now
Tags: BasicResearch, Prevention
- In a recent national study led by Dr. Jane Weeks, 69 percent of those with stage 4 lung cancer and 81 percent of those with stage 4 colon cancer failed to understand that chemotherapy was not at all likely to cure their cancer.
Tags: chemotherapy, EndOfLife
- Dr. Erica Mayer, a medical oncologist at the Susan F. Smith Center for Women's Cancers at Dana-Farber, explained the concerns over soy consumption and its relationship to breast cancer.
- Nine factors explain some of the variance in the quality of life of patients with advanced cancer in end-of-life care, according to a study led by Dr. Holly Prigerson and associates at Dana-Farber and published in the Archives of Internal Medicine.
- Dr. Paul Richardson, clinical director for Dana-Farber's Jerome Lipper Center for Multiple Myeloma, shared the latest prognosis on treating and surviving this disease.
- LIVESTRONG at the West Roxbury Y is an adult cancer survivor program focusing on improving participants' physical health through exercise. Participants are involved in a research project conducted by Dana-Farber and the Yale School of Public Health to gauge the overall effects of the LIVESTRONG program on cancer survivors.
Tags: Exercise, Survivorship
- To commemorate the date of his final chemotherapy treatment, Natick High School vice principal Zach Galvin celebrated his self-proclaimed “Yahoo Day” by donating iTunes gift cards to the Jimmy Fund Clinic.
- Dr. Joseph Antin says it is important for people who have enrolled in a bone marrow donor registry to regularly update the registry whenever their contact information has changed.
- Treated at Dana-Farber by Dr. David Jackman and Dr. Raymond Mak, reporter Bill Shields of WBZ-TV is now cancer free.
Showing 11-20 of 476 items